Cargando…
Individual variation of the SARS‐CoV‐2 receptor ACE2 gene expression and regulation
The COVID‐19 coronavirus is now spreading worldwide. Its pathogen, SARS‐CoV‐2, has been shown to use angiotensin‐converting enzyme 2 (ACE2) as its host cell receptor, same as the severe acute respiratory syndrome coronavirus (SARS‐CoV) in 2003. Epidemiology studies found males although only slightly...
Autores principales: | Chen, Jiawei, Jiang, Quanlong, Xia, Xian, Liu, Kangping, Yu, Zhengqing, Tao, Wanyu, Gong, Wenxuan, Han, Jing‐Dong J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323071/ https://www.ncbi.nlm.nih.gov/pubmed/32558150 http://dx.doi.org/10.1111/acel.13168 |
Ejemplares similares
-
The glycosylation in SARS-CoV-2 and its receptor ACE2
por: Gong, Yanqiu, et al.
Publicado: (2021) -
Variation in the ACE2 receptor has limited utility for SARS-CoV-2 host prediction
por: Mollentze, Nardus, et al.
Publicado: (2022) -
Role of SARS-CoV-2 and ACE2 variations in COVID-19
por: Antony, Priya, et al.
Publicado: (2021) -
Oral cancer and ACE2 receptor of SARS-CoV-2
por: Martelli-Júnior, Hercílio, et al.
Publicado: (2020) -
ACE2-Independent Alternative Receptors for SARS-CoV-2
por: Lim, Suhyeon, et al.
Publicado: (2022)